Loading...
Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC
As shortened telomeres inhibit tumor formation and prolong life span in a Kras(G12D) mouse lung cancer model, we investigated the implications of telomerase in Kras-mutant NSCLC. We found that Kras mutations increased TERT (telomerase reverse transcriptase) mRNA expression and telomerase activity an...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352098/ https://ncbi.nlm.nih.gov/pubmed/27329725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10162 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|